Merck Keytruda Reduces Cervical Cancer Mortality Risk (NYSE:MRK)
Various photographs Merck (New York Stock Exchange:MRK) announced Saturday that its anti-PD-1 therapy Keytruda (pembrolizumab) met the primary endpoint in ...
Tag: NYSEMRK
Merck, Daiichi reject lung cancer therapy in US (NYSE:MRK)
JHVEPhoto The US Food and Drug Administration (FDA) has refused to approve an antibody-drug conjugate known as HER3-DXd developed by ...
Merck halts testing of experimental skin cancer combination therapy (NYSE:MRK)
merck (New York Stock Exchange: MRK) has discontinued the vibostolimab and pembrolizumab coformulation arm of a late-stage skin cancer trial. ...
Merck's Keytruda Reduces Bladder Cancer Risk by 31% (NYSE:MRK)
News by Erik S. Lesser/Getty Images merck (New York Stock Exchange: MRK) announced detailed results from its Phase 3 AMBASSADOR ...
Recommended.
